[New antifungal agents].
Miyazaki
Yoshitsugu
Y
Kawano
Shigeru
S
D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000737:chemistry / Q000494:pharmacology; D001228:Aspergillosis / Q000188:drug therapy; D001232:Aspergillus fumigatus / Q000187:drug effects; D002175:Candida / Q000187:drug effects; D002473:Cell Wall / Q000378:metabolism; D015195:Drug Design; D025141:Drug Resistance, Fungal; D004359:Drug Therapy, Combination; D054714:Echinocandins; D005658:Fungi / Q000166:cytology / Q000378:metabolism; D005964:Glucosyltransferases / Q000037:antagonists & inhibitors; D006801:Humans; D055666:Lipopeptides; D008074:Lipoproteins / Q000627:therapeutic use; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D008565:Membrane Proteins; D000077551:Micafungin; D010456:Peptides, Cyclic / Q000627:therapeutic use; D029702:Schizosaccharomyces pombe Proteins
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D008074:Lipoproteins; D008565:Membrane Proteins; D010456:Peptides, Cyclic; D029702:Schizosaccharomyces pombe Proteins; D000666:Amphotericin B; D005964:Glucosyltransferases; C020570:1,3-beta-glucan synthase; D000077551:Micafungin